(Q49027440)

English

Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients.

scientific article published on 9 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

0 references

quality of life

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

Yoshiharu Tsubakihara

2

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Shunichi Fukuhara

11

object named as

Shunichi Fukuhara

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

9

object named as

Takashi Akiba

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

18

object named as

Tadao Akizawa

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

author name string

Hideki Hirakata

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Fumitake Gejyo

3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Shinichi Nishi

4

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Yasuhiko Iino

5

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Yuzou Watanabe

6

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Masashi Suzuki

7

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Akira Saito

8

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Daijo Inaguma

10

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Satoshi Morita

12

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Michiaki Hiroe

13

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Yoshiyuki Hada

14

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Makoto Suzuki

15

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Makoto Akaishi

16

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Kazutaka Aonuma

17

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

publication date

9 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Clinical and experimental nephrology

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

14

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

28-35

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

https://scigraph.springernature.com/pub.10.1007/s10157-009-0212-4

0 references

Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epoetin trials: randomised controlled trials don't always mimic observational data

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of early correction of anemia on the progression of CKD

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An Ongoing Study of Anemia Correction in Chronic Kidney Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life of predialysis patients with chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemoglobin targets: we were wrong, time to move on

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitization to human leukocyte antigen before and after the introduction of erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10157-009-0212-4

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/19763743

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49027440&oldid=2165186472"